Canada announced Saturday (17) that it had identified a second case within a week of blood clots after inoculation with the AstraZeneca vaccine, although it continues to recommend its use.
The case was observed in a person residing in the province of Alberta (West), who received a copy of the vaccination developed by the Serum Institute in India, Coffeeshield, health officials reported on Twitter.
“The person has received treatment and is recovering,” they added.
Last Tuesday, the first case of a Quebec citizen who was also vaccinated with the same vaccine was announced.
Health officials said that the formation of blood clots as a result of the AstraZeneca vaccine “is still very rare”, and Canada continues to consider that “the benefits of vaccines (…) outweigh the potential risks.”
In late March, the National Immunization Advisory Committee recommended that provinces suspend the use of AstraZeneca immunosuppressants for children under 55 to assess risk.
Canada is in the middle of the third wave of infections.
Since the beginning of the epidemic, the country has accumulated more than 1.1 million infections and nearly 23,500 deaths.
Dumpling recipe with casha
+ Scientists discover a new layer inside the Earth
+ American pancake recipe with chocolate
+ Quick recipe for dulce de leche pie
Contran extends the deadline for CNH renewal
The recipe for fish stew is simple and delicious
+ 5 benefits of intermittent fasting in addition to weight loss
+ Cinema, Sex and the City
+ Lemon squeeze trick is going crazy on social media
A study reveals the healthiest way to cook rice
The shark was caught in MA with the remains of the young missing in the stomach
Giant anacondas are captured on expeditions of photographers in MS